Abrahamsson A, Vazquez Rodriguez G, Dabrosin C. Fulvestrant-mediated attenuation of the innate immune response decreases ER+ breast cancer growth in vivo more effectively than tamoxifen. Cancer Res 2020 Aug 27. pii: 0008-5472.CAN-20-1705.
PMID: 32855207